President Donald Trump’s executive order will have Health Secretary Robert F. Kennedy Jr. broker prices with drugmakers over the next 30 days|@WhiteHouse|X
President Donald Trump signed an executive order on Monday instructing pharmaceutical companies to voluntarily lower drug prices or face government-imposed pricing limits.
Now, Health Secretary Robert F. Kennedy Jr. will negotiate prices with drugmakers over the next 30 days. It could help reduce the prices of medications covered through Medicare and Medicaid, serving nearly 150 million Americans.
It is unclear if the potential price changes will impact millions with private health insurance.
In a press conference, Trump said he wants Americans to pay similar to what Europeans pay. He threatened federal investigations into drug pricing, tariffs on individual pharma companies, and increased medicine imports.
The latest order revives Trump’s controversial drug pricing strategy from his first term, which received legal and pharma pushback.
Big Pharma’s top lobby called Trump’s new plan a “bad deal” that could stall innovation and put American patients at risk.